TheJobsMapVALANX Biotech jobs and careers
Austria
About VALANX Biotech
VALANX has built GoldenSite, a site-specific conjugation platform that places ADC payloads in structurally shielded positions on the antibody, delivering significantly reduced off-target interaction while preserving and enhancing efficacy. Using GoldenSite, we are developing a LIV-1 targeting, differentiated ADC intended to treat metastatic triple-negative-breast cancer.
Founded in 2017 by Michael Lukesch and Patrik Fladischer.
- Founded
- 2017
- Employees
- 11 to 50
- Total funding
- $2.7M
- Headquarters
- Austria
Leadership
The top of VALANX Biotech's org chart, with how many people report into each leader.
MB
Michael Boehler
Chairman of the Board
Jobs at VALANX Biotech
No open positions right now. Explore more companies on TheJobsMap.